LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Synthesis of N‐Substituted Iminosugar Derivatives and Evaluation of Their Immunosuppressive Activities

Photo by bermixstudio from unsplash

It is important to find more effective and safer immunosuppressants, because clinically used immunosuppressive agents have significant side effects. A series of N‐substituted iminosugar derivatives were designed and synthesized, and… Click to show full abstract

It is important to find more effective and safer immunosuppressants, because clinically used immunosuppressive agents have significant side effects. A series of N‐substituted iminosugar derivatives were designed and synthesized, and their immunosuppressive effects were evaluated by the CCK‐8 assay. The results revealed that iminosugars 10 e and 10 i, that is, (3R,4S)‐1‐(4‐heptyloxylphenylethyl)pyrrolidine‐3,4‐diol and (3R,4S)‐1‐[2‐(2‐chloro‐4‐(p‐tolylthio)‐phenyl‐1‐yl)ethyl]pyrrolidine‐3,4‐diol, respectively, exhibited the strongest inhibitory effects on mouse splenocyte proliferation (IC50=2.16 and 2.48 μm, respectively), whereas the iminosugars containing an amide group near the hydrophilic head (compounds 10 j–n) exhibited no inhibitory effects. Further studies revealed that the inhibitory effects on splenocyte proliferation may have come from the suppression of both IFN‐γ and IL‐4 cytokines. Our results suggest that synthetic iminosugars, especially compounds 10 e and 10 i, hold potential as immunosuppressive agents.

Keywords: inhibitory effects; derivatives evaluation; substituted iminosugar; synthesis substituted; iminosugar derivatives; evaluation immunosuppressive

Journal Title: ChemMedChem
Year Published: 2018

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.